CPQR supports the consistent use of PRO in Canadian radiation treatment programs to improve the clinical encounter for patients. Promoting the use of the same Patient Reported Outcome Measures (PROM) across the country will also help facilitate big data analysis against treatment outcomes which may be used to inform population-based decisions regarding optimal care. The CPQR-endorsed measure for PROs are as follows:

Disease site: General symptom screening
Endorsed measure: Edmonton Symptom Assessment Screening (ESAS)
Description: A paper-based questionnaire used to rate the intensity of nine common symptoms experienced by cancer patients, including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being and shortness of breath.

Disease site: Bone metastasis
Endorsed measure: Brief pain inventory
Description: A form to assess the severity of patient’s pain and the impact of pain on daily functions.

Disease site: Early-stage prostate cancer
Endorsed measure: Expanded prostate cancer index composite (EPIC)
Description: A self-report scale designed to measure the health-related quality of life among prostate cancer patients

Disease site: Head and neck cancer
Endorsed measure: MD Anderson symptom inventory for head and neck (HDASI-HN)
Description: A multi-symptom PRO measure for clinical and research use to assess the severity of symptoms experienced by patients with cancer and the interference with daily living caused by these symptoms.

Disease site: Cervical and other gynecological cancers
Endorsed measure: Cervical cancer EORTC QLQ-CX24
Description: Developed by the European Organization for the Research and Treatment of Cancer, the cervical cancer module is an extension of their basic quality of life measure. It consists of 3 multiitem scales and 5 single-item scales and is designed to assess disease and treatment-specific aspects of quality of life in patients with cervical cancer.